
|Articles|September 23, 2015
Shaji Kumar on Treatment-Related Adverse Events From Monoclonal Antibodies
Author(s)Shaji Kumar
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
Advertisement
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
The main adverse event that is seen is infusion reactions, Kumar says. These reactions are easily managed and, even so, usually go away on their own.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Taking Back the Razor: Choosing Power in the Face of Hair Loss
2
The Cost of the Unicorn: Why Pancreatic Cancer Survival Isn't a Marathon
3
The Current Treatment Landscape in Multiple Myeloma
4
Tukysa May Be ‘Patient Friendly’ Frontline Maintenance Option in HER2+ Breast Cancer
5




